Santen Pharmaceutical Co Ltd
TSE:4536

Watchlist Manager
Santen Pharmaceutical Co Ltd Logo
Santen Pharmaceutical Co Ltd
TSE:4536
Watchlist
Price: 1 670.5 JPY 0.39% Market Closed
Market Cap: 606.7B JPY
Have any thoughts about
Santen Pharmaceutical Co Ltd?
Write Note

Santen Pharmaceutical Co Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Santen Pharmaceutical Co Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Santen Pharmaceutical Co Ltd
TSE:4536
Cash from Operating Activities
ÂĄ82.2B
CAGR 3-Years
34%
CAGR 5-Years
15%
CAGR 10-Years
15%
Takeda Pharmaceutical Co Ltd
TSE:4502
Cash from Operating Activities
ÂĄ876.3B
CAGR 3-Years
-5%
CAGR 5-Years
10%
CAGR 10-Years
14%
Daiichi Sankyo Co Ltd
TSE:4568
Cash from Operating Activities
ÂĄ583.9B
CAGR 3-Years
73%
CAGR 5-Years
25%
CAGR 10-Years
17%
Otsuka Holdings Co Ltd
TSE:4578
Cash from Operating Activities
ÂĄ379.8B
CAGR 3-Years
16%
CAGR 5-Years
11%
CAGR 10-Years
8%
Chugai Pharmaceutical Co Ltd
TSE:4519
Cash from Operating Activities
ÂĄ409.9B
CAGR 3-Years
17%
CAGR 5-Years
21%
CAGR 10-Years
27%
Astellas Pharma Inc
TSE:4503
Cash from Operating Activities
ÂĄ172.9B
CAGR 3-Years
-19%
CAGR 5-Years
-5%
CAGR 10-Years
-3%
No Stocks Found

Santen Pharmaceutical Co Ltd
Glance View

Market Cap
594.1B JPY
Industry
Pharmaceuticals

Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. The company is headquartered in Osaka, Osaka-Fu and currently employs 4,229 full-time employees. The firm has medical pharmaceutical business, OTC drugs business, medical devices business and other businesses. The firm engages in manufacture, sale and clinical development of medical pharmaceutical products, the development, manufacturing and sales of medical equipment, as well as the cleaning business. The firm operates in Japan, Europe, Asia, North America markets.

Intrinsic Value
2 142.23 JPY
Undervaluation 22%
Intrinsic Value
Price

See Also

What is Santen Pharmaceutical Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
82.2B JPY

Based on the financial report for Jun 30, 2024, Santen Pharmaceutical Co Ltd's Cash from Operating Activities amounts to 82.2B JPY.

What is Santen Pharmaceutical Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
15%

Over the last year, the Cash from Operating Activities growth was 121%. The average annual Cash from Operating Activities growth rates for Santen Pharmaceutical Co Ltd have been 34% over the past three years , 15% over the past five years , and 15% over the past ten years .

Back to Top